Accuray Incorporated (NASDAQ:ARAY) Stocks Fall 13% in a Month: Here is Why

July 15, 2021July 30, 2021 Pete Matthews Accuray Incorporated (NASDAQ:ARAY), ARAY, ARAY news, ARAY stock, NASDAQ:ARAY

Accuray Incorporated (NASDAQ:ARAY) is down 13% in a month. The company has announced that it will report its Q4 and FY 2021 financial results for the years ended June 30, 2021, on August 11, 2021, after the market closes, followed by a management conference call to discuss the results.

Recently the company launched RayStation* treatment planning support for its CyberKnife M6 and S7 Robotic Radiotherapy Systems. It is vital to note that RayStation is critical to clinicians in helping devise treatment models for CyberKnife M6 and S7 Systems.

In addition, it is essential in standard radiation therapy tools in a unified treatment planning system, and it makes it effortless to incorporate Accuray systems in radiation oncology units. The combination of RayStation and Accuray information management system, iDMS, can offer unified data integration and treatment planning platform for CyberKnife treatments. In addition, RayStation offers support for treatment plans creation leveraging the potential of CyberKnife M6 and S7 systems. So in the coming weeks, ARAY is a stock to watch.

Market Reaction:

On Wednesday, ARAY stock fell over 2% at $4.18 with more than 399k shares, compared to its average volume of 740k shares. The stock had moved within a range of $4.1600 – 4.4000 after opening the trade at $4.31. Over the past 52-week, the stock has been trading within a range of $2.1000 – 6.0200.

Pete Matthews

Pete attended the University of Colorado and still calls the centennial state home. He chases trout in the summer and snowboards in the winter. He is fascinated with the markets and has a strong interest in nanocap stocks and crypto currency.